Tara Lynn Kieffer, Chief Product Strategy Officer at ENANTA PHARMACEUTICALS INC (ENTA), sold 2,106 shares at $14.23 ($30K) on 2025-12-05, disclosed to the SEC on 2025-12-05.
Seasonal sale ($30k) by Chief Product Strategy Officer — this insider has traded ENTA in December in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| ENTA | SELL | 2023-12-06 | $20K | — | Filing → |